Pfizer has terminated development of its RSV treatment candidate sisunatovir, a viral inhibitor picked up in its up to $525 ...

A potential new benefit for to provide home health care for seniors unveiled by Vice President Kamala Harris would likely be ...

Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and GSK said it expects revaccination will eventually be needed.

Mitem Pharma acquired from Novartis worldwide rights to Desferal, commonly used to lower excessive iron levels induced by ...

Pfizer Inc.'s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug company. Bondholders seem to like the news too. Spreads on the company's ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

Pfizer's former CEO and CFO relayed proposals from activist investor Starboard Value to several members of the company's ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes ...

Reliance Retail is the latest entrant in the quick commerce market, taking on the likes of Blinkit, Instamart and Zepto.

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.